RRMGX
Price
$87.66
Change
+$0.20 (+0.23%)
Updated
Nov 18 closing price
Net Assets
25.05B
SMFAX
Price
$32.82
Change
+$0.04 (+0.12%)
Updated
Nov 18 closing price
Net Assets
712.92M
Interact to see
Advertisement

RRMGX vs SMFAX

Header iconRRMGX vs SMFAX Comparison
Open Charts RRMGX vs SMFAXBanner chart's image
T. Rowe Price Mid-Cap Growth R
Price$87.66
Change+$0.20 (+0.23%)
VolumeN/A
Net Assets25.05B
American Beacon Stephens Mid-Cap Gr A
Price$32.82
Change+$0.04 (+0.12%)
VolumeN/A
Net Assets712.92M
RRMGX vs SMFAX Comparison Chart in %
View a ticker or compare two or three
VS
RRMGX vs. SMFAX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RRMGX is a Hold and SMFAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 25B vs. SMFAX (713M). RRMGX (0.00) and SMFAX (0.00) have matching dividends . RRMGX was incepted earlier than SMFAX: RRMGX (23 years) vs SMFAX (14 years). SMFAX (1.39) is less costly to investors than RRMGX (1.29). SMFAX is a more actively managed with annual turnover of: 24.00 vs. RRMGX (22.60). RRMGX (2500) and SMFAX (2500) have matching initial minimum investment requirements. SMFAX annual gain was more profitable for investors over the last year : 2.79 vs. RRMGX (-10.65). SMFAX return over 5 years is better than : 15.73 vs. RRMGX (-15.04).
RRMGXSMFAXRRMGX / SMFAX
Total Expense Ratio1.291.21107%
Annual Report Gross Expense Ratio1.291.3993%
Fund Existence23 years14 years-
Gain YTD-0.2968.856-3%
Front LoadN/A6%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets25B713M3,506%
Annual Yield % from dividends0.000.00-
Returns for 1 year-10.652.79-382%
Returns for 3 years4.7238.8312%
Returns for 5 years-15.0415.73-96%
Returns for 10 years12.6793.7214%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRCE3.160.16
+5.33%
Grace Therapeutics Inc
RYAN56.950.36
+0.64%
Ryan Specialty Holdings
GLP42.410.11
+0.26%
Global Partners LP
FTAIM26.88-0.11
-0.41%
FTAI Aviation Ltd
XFOR3.61-0.05
-1.37%
X4 Pharmaceuticals Inc